707 related articles for article (PubMed ID: 15037694)
1. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.
Ingelsson M; Fukumoto H; Newell KL; Growdon JH; Hedley-Whyte ET; Frosch MP; Albert MS; Hyman BT; Irizarry MC
Neurology; 2004 Mar; 62(6):925-31. PubMed ID: 15037694
[TBL] [Abstract][Full Text] [Related]
2. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.
Yamaguchi H; Sugihara S; Ogawa A; Oshima N; Ihara Y
J Neuropathol Exp Neurol; 2001 Jul; 60(7):731-9. PubMed ID: 11444802
[TBL] [Abstract][Full Text] [Related]
4. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation.
Koller EJ; Ibanez KR; Vo Q; McFarland KN; Gonzalez De La Cruz E; Zobel L; Williams T; Xu G; Ryu D; Patel P; Giasson BI; Prokop S; Chakrabarty P
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12779. PubMed ID: 34825397
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
7. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
Togo T; Dickson DW
Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
VanItallie TB
Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
[TBL] [Abstract][Full Text] [Related]
9. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains.
Pirttilä T; Soininen H; Mehta PD; Heinonen O; Lehtimäki T; Bogdanovic N; Paljärvi L; Kim KS; Kosunen O; Winblad B; Riekkinen P; Wisniewski HM
Neurobiol Aging; 1997; 18(1):121-7. PubMed ID: 8983040
[TBL] [Abstract][Full Text] [Related]
11. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.
Blennow K; Bogdanovic N; Alafuzoff I; Ekman R; Davidsson P
J Neural Transm (Vienna); 1996; 103(5):603-18. PubMed ID: 8811505
[TBL] [Abstract][Full Text] [Related]
12. A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls.
Savioz A; Giannakopoulos P; Herrmann FR; Klein WL; Kövari E; Bouras C; Giacobini E
Neurodegener Dis; 2016; 16(5-6):398-406. PubMed ID: 27400224
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
[TBL] [Abstract][Full Text] [Related]
14. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
15. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
16. Clinical validity of A beta-protein deposition staging in brain aging and Alzheimer disease.
Gold G; Kövari E; Corte G; Herrmann FR; Canuto A; Bussière T; Hof PR; Bouras C; Giannakopoulos P
J Neuropathol Exp Neurol; 2001 Oct; 60(10):946-52. PubMed ID: 11589425
[TBL] [Abstract][Full Text] [Related]
17. Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
Thal DR; Ronisz A; Tousseyn T; Rijal Upadhaya A; Balakrishnan K; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Otto M; Beach TG; Lilja J; Heurling K; Chakrabarty A; Ismail A; Buckley C; Smith APL; Kumar S; Farrar G; Walter J
Acta Neuropathol Commun; 2019 Nov; 7(1):178. PubMed ID: 31727169
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation.
Petersen C; Nolan AL; de Paula França Resende E; Miller Z; Ehrenberg AJ; Gorno-Tempini ML; Rosen HJ; Kramer JH; Spina S; Rabinovici GD; Miller BL; Seeley WW; Heinsen H; Grinberg LT
Acta Neuropathol; 2019 Oct; 138(4):597-612. PubMed ID: 31250152
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.
Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH
Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099
[TBL] [Abstract][Full Text] [Related]
20. DNA fragmentation, gliosis and histological hallmarks of Alzheimer's disease.
Overmyer M; Kraszpulski M; Helisalmi S; Soininen H; Alafuzoff I
Acta Neuropathol; 2000 Dec; 100(6):681-7. PubMed ID: 11078220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
